bpc 157 back pain reddit BPC-157 vs TB-500: Recovery Peptide Comparison If BPC-157 worked as well
Description
No contract or commitment.
If this is adhered to, most patients notice prolonged pain relief
A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism
Normal rats
